Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma
Go back to Cerus Receives FDA Approval for Use of the INTERCEPT Blood System for Platelets Suspended in 100% Plasma| Cerus Corp (NASDAQ: CERS) | Delayed: 2.60 -0.05 (1.89%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.65 | 52 Week High | $7.64 | |||
| Open | $2.65 | 52 Week Low | $4.22 | |||
| Day High | $2.65 | P/E | N/A | |||
| Day Low | $2.59 | EPS | $-0.59 | |||
| Volume | 125,618 | |||||
